Global Medical (02666.HK): Robust Growth in Revenue and Profit, New Breakthroughs in Industrial Development

Revenue and profit achieved steady growth in 2025, with profit maintaining stable growth in the first quarter of 2026. In 2025, the company generated revenue of 14.94 billion (+9.3%). Of this, healthcare business revenue amounted to 9.902 billion.

Guosen SecuritiesMay 7 19:32

Global Medical (02666) reported a year-on-year increase of approximately 4.8% in net profit attributable to ordinary shareholders for the first quarter of 2026.

Universal Medical (02666) announced that in the first quarter of 2026, the group's overall operations showed steady improvement, with significant progress achieved in key areas of focus. For the three months ended March 31, 2026, the group’s revenue decreased by approximately 4.5% compared to the same period last year, primarily due to a decline in financial services revenue. However, profit for the period increased by about 5.2% year-over-year, mainly driven by optimized funding cost management and reduced costs associated with medical services. Profit attributable to ordinary shareholders for the period rose by approximately 4.8% compared to the same period last year.

Zhitong FinanceApr 29 12:52

UNI MEDICAL: UNAUDITED OPERATION SUMMARY OF THE GROUP FOR THE FIRST QUARTER OF 2026

HKEXApr 29 12:14 · Announcements

Genertec Universal Medical Seeks Higher Cap on Connected Procurement Deal

TipRanksApr 27 18:09

Genertec Universal Medical Unit Sells 500 Million Yuan Bonds

MT NewswiresApr 27 17:52

Global Medical (02666) subsidiary completes issuance of 500 million yuan medium-term notes

Global Medical (02666) announced that its wholly-owned subsidiary, China Global Leasing Co., Ltd., has completed the issuance of the first tranche of domestic medium-term notes in 2026 with a total principal amount of up to RMB 500 million. The company is pleased to announce that the notes were successfully issued in China on April 24, 2026, with an actual issuance amount of RMB 500 million. The notes will mature two years from April 27, 2026, bearing a fixed interest rate of 1.75%. The issue price was RMB 100.0 per note, equivalent to 100% of the face value of the notes.

Zhitong FinanceApr 27 16:55